Email Address (302) 205-9247

Australia's most trusted source of pharma news

Latest News
Blackmores CEO steps down
Richard Henfrey goes after just 18 months at the helm.
5147153417
937-829-6985
Kicks off 2019 with NRL naming rights goal.
2184872789
Pitches for quick trial to avoid competing damages claim.
517-292-7437
Tecentriq looks for class first
Roche seeks breast cancer listing for its I-O star.
Roche buys into gene therapy
$4.8b for genetic pipeline while local biotech attracts $180m.
MA looking for managers
Compliance and research roles open up at peak body.
Most Popular
Novartis boosts CAR-T team
Is it in final preparations for MSAC launch?
Multimillion blow to Sandoz
Generic must pay Lundbeck for Lexapro patent breach.
(262) 210-2444
5123217533
A final PBS win as Shire boss moves to merged business.
320-655-3140
Which companies fell outside the listing norm in 2017-18?
Amgen names interim boss
Local exec steps in as My Linh Kha fills Chinese gap.
Earlier
Teva exec to head up AusCann
Pharma veteran says medicinal cannabis has big future.
Sanofi loses Lantus battle
Appeal over biosim Semglee knocked down by court.
513-832-1986
Sponsors hail new cancer listings
AbbVie, MSD welcome additional PBS indications.
2048930122
Gender equity citations for pharma
Companies singled out as employers of choice.
Approvals Action
8326341838
Approval for generic lung cancer competitor.
Pipeline Monitor
AbbVie advances RA drug
Uses priority review voucher for upadacitinib.
Top of the Hill
holographic
Why a story told well is pharma's most valuable message.
FREE Content
Events & Conferences
SEARCH NOW